Skip to main content
Clinical Trials/NCT04582162
NCT04582162CompletedNot Applicable

Comparison of Short Implant Assisted Mandibular Overdenture Designs (A Randomized Clinical Trial)

Nourhan M.Aly1 site in 1 country12 target enrollmentStarted: December 5, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
12
Locations
1
Primary Endpoint
Crestal bone loss

Study Overview

Brief Summary

The aim of the study was to clinically and radiographically evaluate and compare the use of unsplinted and splinted short implants with ball abutments to support mandibular overdentures in cases with severe mandibular ridge resorption.

Detailed Description

Twelve patients from the Prosthodontics Department in the Faculty of Dentistry, Alexandria University participated in the study. Patients were divided into 2 groups. The test group received 4 short implants with ball abutments for the construction of a mandibular assisted overdenture, while the control group received 4 short implants splinted using a bar with a ball attachment for retaining a mandibular overdenture.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
20 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Completely edentulous patients.
  • •Mandibular ridge should be a maximum of 10mm height and with a minimum width of 8 mm to insert implants without grafting procedures.
  • •Patients free from systemic diseases that contradict the use of dental implants.
  • •Patients with class I ridge relation.
  • •Patients with adequate zone of keratinized mucosa.
  • •Patients with U-shaped or square shaped arches

Exclusion Criteria

  • •Non-compliant patients based on history.
  • •Heavy smokers.
  • •Senile patients (over 75 years) with impaired neuromuscular control.

Arms & Interventions

Unsplinted implants

Experimental

Intervention: Unsplinted implants (Other)

Splinted implants

Active Comparator

Intervention: Splinted implants (Other)

Outcomes

Primary Outcomes

Crestal bone loss

Time Frame: up to 12 months

Mesial and Distal crestal bone loss were evaluated using digital periapical x-rays. In order to standardize the cones' and sensors' position and angulation, a film positioning system was used along with a customized silicone bite.

Implant stability

Time Frame: up to 12 months

Stability was assessed using resonance frequency analysis measured with the Osstell device instrument. The Osstell unit records a numeric value of 1-100 which is referred to as the implant stability quotient (ISQ). The measurements were performed and 3 mean of three readings were recorded in each evaluation period.

Peri-implant probing depth

Time Frame: up to 12 months

Peri-implant probing depth refers to the distance between the gingival margin and the most apically probable portion in millimeters (mm). The peri-implant probing depth was measured using a graduated plastic periodontal probe. The probe was held parallel to the long axis of the implant and introduced to the peri-implant sulcus until slight resistance was felt. Measurements were made at four sites around each implant; buccal, lingual, mesial and distal. Probing depth of 1 mm or less was recorded as "1mm", and those exceeding 1 mm but less than 2 mm were recorded as "2mm" and so forth. The mean records for each implant were then calculated.

Clinical attachment loss

Time Frame: up to 12 months

It is the distance from the junction implant/abutment to the most apically probable portion, in millimeters. Assessment of the clinical attachment level was performed simultaneously while measuring the peri-implant probing depth.

Gingival inflammation (Modified gingival index)

Time Frame: up to 12 months

The peri-implant mucosal tissues around the implants were assessed using Apse's modification of Löe and Silness index. The criteria for assessment were: 0 =Normal mucosa, 1 =Mild inflammation, slight change in colour and texture, slight oedema and no bleeding on probing, 2 =Mild inflammation, redness, in all portions of gingival margin, 3 =Moderate inflammation, 4 =Severe inflammation. The gingival index was assessed at 4 sites around each implant (buccal, lingual, mesial and distal) the sum gingival index score was calculated from all these surfaces and then divided by 4 to obtain the gingival index for each implant. Indices of the three implants were added to each other, and then divided by 3 to get the mean gingival index for each case. A score from 0.1-1.0 reflects mild inflammation; 1.1-2.0 reflects moderate inflammation from, and 2.1-3.0 signifies severe inflammation.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Nourhan M.Aly
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Nourhan M.Aly

Assistant Lecturer of Dental Public Health

University of Alexandria

Study Sites (1)

Loading locations...

Similar Trials

Comparison of Short Implant Assisted... | Clinical Trial